Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease

William T. Harris(University of Alabama at Birmingham), Eric J. Sorscher(Emory University), Mark MacEwen(University of Alabama at Birmingham), Namasivayam Ambalavanan(University of Alabama at Birmingham), Yong Zhou(Tulane University), Dezhi Wang(University of Alabama at Birmingham), James S. Hagood(University of North Carolina at Chapel Hill), John P. Clancy(Cystic Fibrosis Foundation), David R. Kelly(Children's of Alabama)
PLoS ONE
August 12, 2013
10.1371/journal.pone.0070196
Cited by 85

Related Papers

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation
|New England Journal of Medicine|2010|802
Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study
|The Lancet Child & Adolescent Health|2017|722
Matrix Stiffness–Induced Myofibroblast Differentiation Is Mediated by Intrinsic Mechanotransduction
|American Journal of Respiratory Cell and Molecular Biology|2012|527
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|496
Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis
|Journal of Clinical Investigation|2013|472